Can I Take Glutathione with Vardenafil (Levitra/Staxyn)?

What Is the Interaction Between Glutathione and Vardenafil?

The interaction between glutathione and vardenafil operates on two distinct pathways: pharmacokinetic (how each substance is processed) and pharmacodynamic (what each substance does in the body). At standard oral supplement doses, the overlap is minimal. High-dose intravenous glutathione introduces a more meaningful risk of additive vasodilation that warrants clinician review.

Pharmacokinetic Pathway: CYP3A4

Vardenafil is metabolized primarily by cytochrome P450 3A4 (CYP3A4) in the liver, with minor contributions from CYP3A5 and CYP2C9 [1]. Glutathione itself is not a direct CYP3A4 inhibitor or inducer at physiologic concentrations. However, oxidative stress suppresses CYP3A4 expression, and glutathione, as the body's principal intracellular antioxidant, may partially restore CYP3A4 activity when stores have been depleted [2]. This indirect modulation is unlikely to alter vardenafil plasma levels in a clinically meaningful way for most men taking 250 to 1,000 mg oral glutathione daily.

Oral glutathione bioavailability is also limited. A randomized trial published in the European Journal of Nutrition (N=54) found that 250 mg/day of oral glutathione for 4 weeks raised whole-blood glutathione by 30 to 35% but had no reported effect on hepatic drug-metabolizing enzymes [3]. That degree of enzymatic neutrality suggests CYP3A4-mediated clearance of vardenafil is not meaningfully changed.

Pharmacodynamic Pathway: Nitric Oxide Overlap

Vardenafil inhibits phosphodiesterase type 5 (PDE5), which prolongs the action of cyclic guanosine monophosphate (cGMP) and sustains nitric oxide (NO)-mediated smooth muscle relaxation in penile vasculature [4]. Glutathione supports NO bioavailability by reducing oxidative degradation of NO and by regenerating tetrahydrobiopterin (BH4), a cofactor required for endothelial nitric oxide synthase (eNOS) function [5].

When both agents are present simultaneously, the combined effect on NO signaling may be additive. For oral glutathione at supplement doses, this additive effect is subtle and unlikely to produce symptomatic hypotension in otherwise healthy men. For intravenous glutathione at doses of 1,200 to 2,400 mg per infusion, the NO-potentiating effect is stronger and more acute, raising a legitimate concern about excessive blood pressure reduction when taken close in time to vardenafil [6].

How Does Vardenafil Work, and Why Does It Matter for Supplement Safety?

Vardenafil (brand names Levitra and Staxyn) is a selective PDE5 inhibitor approved by the FDA for erectile dysfunction [7]. It reaches peak plasma concentration (Tmax) approximately 60 minutes after oral ingestion, with a half-life of 4 to 5 hours [1]. Because it depends heavily on hepatic CYP3A4 for clearance, any substance that meaningfully inhibits or induces this enzyme can raise or lower vardenafil exposure substantially.

Drugs Known to Interact via CYP3A4

Strong CYP3A4 inhibitors such as ketoconazole (400 mg) can increase vardenafil AUC by up to 10-fold, which is why the FDA label restricts co-administration [7]. Strong CYP3A4 inducers such as rifampicin reduce vardenafil exposure dramatically. Glutathione does not appear on any current FDA drug-interaction table for vardenafil, nor does it appear in the Natural Medicines database as a clinically significant CYP3A4 modulator at oral supplement doses [8].

The Nitrate Contraindication Context

Vardenafil carries a strict contraindication with organic nitrates of any form because combined NO pathway stimulation produces severe hypotension [7]. Glutathione is not a nitrate and does not directly donate NO. Its pro-NO effects operate through enzyme support rather than direct NO donation. This distinction is important: glutathione does not trigger the nitrate contraindication, but it may still contribute modestly to vasodilation in high-dose intravenous form.

What Is Glutathione and Why Do Men Take It?

Glutathione (gamma-L-glutamyl-L-cysteinylglycine) is a tripeptide synthesized from glutamate, cysteine, and glycine. It serves as the body's primary endogenous antioxidant, present in virtually every cell [2]. Men pursuing sexual health optimization sometimes add glutathione supplementation for its antioxidant, skin-brightening, or general cellular health effects.

Oral vs. Injectable Glutathione: A Critical Distinction

Oral glutathione capsules and sublingual formulations typically deliver 250 to 1,000 mg per day. Bioavailability through the oral route is modest; much of the ingested glutathione is broken down by intestinal peptidases before systemic absorption [3]. Liposomal oral formulations improve absorption somewhat, but peak plasma increases remain moderate.

Injectable or intravenous glutathione, used in some aesthetic medicine and functional medicine clinics, delivers 600 to 2,400 mg directly into circulation, bypassing first-pass degradation entirely. Systemic antioxidant and vasodilatory effects are faster and more pronounced [6]. This formulation creates more meaningful overlap with vardenafil's vasodilatory mechanism.

Glutathione and Erectile Function: Is There a Benefit?

Oxidative stress in the corpus cavernosum contributes to endothelial dysfunction and reduced NO bioavailability, a recognized mechanism underlying arteriogenic erectile dysfunction [5]. A 2021 review in Antioxidants noted that oxidative stress biomarkers including reduced glutathione were significantly lower in men with erectile dysfunction compared to controls [9]. Restoring glutathione levels may therefore support the same vascular environment that PDE5 inhibitors act on. This raises the theoretical possibility that combining both could produce better outcomes than either alone, though no randomized controlled trial has tested this specific combination to date.

The HealthRX clinical team uses a three-tier assessment framework when evaluating supplement-drug combinations for patients on PDE5 inhibitors:

Tier 1 (Low concern): Supplement has no known CYP3A4 activity, no direct NO donation, and no hypotensive effect at typical doses. Oral glutathione falls here.

Tier 2 (Moderate concern): Supplement has indirect vasodilatory or CYP3A4 modulatory effects at high or parenteral doses. IV glutathione falls here.

Tier 3 (High concern / contraindicated): Supplement acts as a direct NO donor or strong CYP3A4 inhibitor/inducer. Organic nitrates and high-dose grapefruit extract fall here.

Is Oral Glutathione Safe to Take with Vardenafil?

Yes, for most men, oral glutathione at standard supplement doses (250 to 1,000 mg/day) may be taken with vardenafil without clinically significant risk. No published pharmacokinetic study has shown that oral glutathione alters vardenafil's Cmax, AUC, or Tmax in a meaningful direction [8].

What the Evidence Shows

The European Journal of Nutrition trial cited above (N=54, 250 mg/day for 4 weeks) demonstrated systemic glutathione elevation without hepatic enzyme disruption [3]. A separate study in Integrative Medicine: A Clinician's Journal (N=60) examining liposomal glutathione at 500 mg/day found no significant changes in standard liver function panels or reported drug interactions in participants taking concurrent medications [10].

Neither the FDA prescribing information for Levitra nor the Staxyn label lists glutathione as a compound requiring dose adjustment or avoidance [7]. The absence of a listed interaction does not guarantee zero effect, but it does reflect a lack of clinical signal across the pharmacovigilance record.

Practical Guidance for Oral Supplementation

Men who take vardenafil 10 mg approximately 60 minutes before sexual activity and also take a daily oral glutathione supplement do not need to separate the doses by any specific window based on current evidence. Taking glutathione in the morning and vardenafil as needed in the evening is a reasonable pattern, though no specific schedule has been proven superior.

What About Intravenous or High-Dose Glutathione with Vardenafil?

This combination warrants a more careful conversation with a prescribing clinician. IV glutathione doses of 1,200 to 2,400 mg per infusion can acutely raise systemic NO bioavailability and reduce peripheral vascular resistance [6]. Vardenafil is already a vasodilator; its prescribing information notes that it can lower systolic blood pressure by approximately 6 to 8 mmHg in controlled studies [7].

The Hypotension Risk

If IV glutathione produces an additional 3 to 5 mmHg reduction in systolic pressure through enhanced NO signaling, the combined effect in a susceptible individual could be sufficient to cause symptomatic hypotension, defined as systolic pressure <90 mmHg with symptoms such as lightheadedness or syncope [11]. Men with baseline blood pressure already in the lower-normal range (systolic 100 to 110 mmHg) face a proportionally greater risk.

A 2019 study in Clinical and Experimental Hypertension (N=40) examining IV glutathione in hypertensive patients found a mean systolic blood pressure reduction of 5.2 mmHg at 1,200 mg doses [6]. Combined with vardenafil's known 6 to 8 mmHg reduction, the theoretical combined effect approaches 11 to 13 mmHg, which may cross the symptomatic threshold in some men.

Recommended Approach for IV Glutathione Users

Men receiving IV glutathione infusions at a functional medicine or aesthetic clinic should disclose their vardenafil prescription to both their infusion provider and their prescribing clinician. A minimum separation of 24 hours between an IV glutathione infusion and a dose of vardenafil is a reasonable precaution, given vardenafil's 4 to 5 hour half-life and the acute hemodynamic effects of IV glutathione. This recommendation is conservative and based on pharmacodynamic reasoning rather than a published controlled trial.

Monitoring and What to Do If You Are Already Taking Both

Men already combining daily oral glutathione with vardenafil do not need to stop either agent based on current evidence. Self-monitoring for symptoms of low blood pressure, including dizziness, lightheadedness on standing, or palpitations, is prudent whenever adding any vasodilatory supplement to a PDE5 inhibitor regimen.

Signs That Warrant Medical Attention

• Systolic blood pressure below 90 mmHg on home monitoring
• Fainting or near-fainting after taking vardenafil
• Severe headache, vision changes, or prolonged erection lasting more than 4 hours (priapism)

Priapism requires emergency evaluation regardless of supplement use. Per the American Urological Association guidelines on erectile dysfunction, any erection lasting beyond 4 hours is a urological emergency [12].

Lab Monitoring

No specific lab panel is required for the oral glutathione-vardenafil combination. Clinicians managing men on IV glutathione who also use PDE5 inhibitors may consider periodic blood pressure checks within 2 hours of vardenafil dosing. Liver function tests are not altered by oral glutathione at standard doses and do not require additional monitoring in this context [3].

Vardenafil Drug Interactions: Context for Supplement Users

Understanding where glutathione sits relative to known vardenafil interactions provides useful perspective. The FDA label for Levitra identifies the following as clinically significant interactions requiring dose adjustment or avoidance [7]:

• Alpha-blockers (e.g., tamsulosin, doxazosin): additive hypotension; dose initiation guidance required
• Strong CYP3A4 inhibitors (e.g., ketoconazole 400 mg, ritonavir): up to 10-fold AUC increase; co-administration with ritonavir is contraindicated
• Organic nitrates (e.g., nitroglycerin, isosorbide mononitrate): severe hypotension; absolute contraindication
• Moderate CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): vardenafil dose should not exceed 5 mg per 24 hours

Glutathione at oral supplement doses does not belong in any of these categories. This comparative context reinforces that the glutathione-vardenafil combination is a low-priority interaction concern for most men.

Specific Populations and Considerations

Men with Liver Disease

Hepatic impairment reduces CYP3A4 capacity and already elevates vardenafil exposure. Men with Child-Pugh Class B hepatic impairment are limited to a maximum vardenafil dose of 5 mg per labeled guidance [7]. If glutathione is being used therapeutically for liver support in this context, the prescriber managing both conditions should confirm that hepatic drug clearance has been assessed before adjusting any dose.

Men Over 65

Older men have both reduced CYP3A4 activity and higher baseline cardiovascular risk. The FDA label recommends starting vardenafil at 5 mg in men over 65 [7]. Adding a vasodilatory supplement in this population warrants more conservative blood pressure monitoring, particularly with IV glutathione.

Men on Testosterone Replacement Therapy

Men on TRT who also use vardenafil may take glutathione without specific added concern. Testosterone does not significantly alter CYP3A4 activity at standard TRT doses, and no pharmacokinetic interaction with glutathione has been documented [13].